Ben Davis, MD, has been the CEO of PathGroup in Brentwood, TN—one of the oldest and most successful pathology practices in the country—for more than two decades. Under his leadership, PathGroup has grown immensely and maintained its status as a private practice. With more than 80 pathologists, PathGroup serves more than 70 hospitals and thousands of physicians throughout the United States.
Over the years, PathGroup has faced all of the same problems that every pathology practice has endured—reimbursement pressures, compliance pressures, regulatory pressures, audits—and found ways to succeed despite these and other headwinds that have confronted the industry.
Davis has successfully led PathGroup through the battles and learned many valuable lessons along the way. During an all-new webinar, “Private Practice Pathology – Today’s Reality and Tomorrow’s Opportunities with More Access to Managed Care Contracts, Regional Pathology Consolidation, Pathologist Productivity and Compensation, and Getting Paid for Claims,” being presented Wednesday, February 28, 2017, Davis will share with participants those lessons, in addition to insights on best managing the myriad new issues confronting pathology practices as they move forward.
Davis will discuss PathGroup’s process of self-evaluation, as it positions itself internally for growth, and externally to deal with expansion. You’ll hear about internal procedures that PathGroup has implemented to assure quality, service, and better patient outcomes, how the organization appraises potential acquisition targets, and metrics that PathGroup employs to determine how to most effectively deal with competition.
Next, you’ll hear from Kathleen Fondren, CEO, and David Corwin, Medical Director and President, of CellNetix in Seattle, WA. Fondren spent 27 years working her way up the ranks at CHI Franciscan Highline Medical Center system. She is an expert in the operations side of laboratory medicine, and brings a wealth of business acumen and experience to this webinar. Corwin is an acclaimed clinical pathologist and serves as a Clinical Associate Professor of Pathology at the University of Washington.
Together, they have led CellNetix on a path of independence and growth while it serves much of the Pacific Northwest. Learn from the insights they have gained during the company’s history of expansion, and gain new strategies that your own laboratory can use to manage current and looming issues. Among the topics to be discussed will be dealing with reimbursement, compliance and regulatory issues, and drivers that can enable your lab to maintain consistent growth and to withstand attacks that may come your way.
CellNetix itself has a history of mergers and acquisitions which makes its insights of particular value to participants, as Fondren and Corwin discuss their approach to M&A and their metrics for determining value. They will provide practical experience regarding the factors they consider important in evaluating a potential target, or avoiding being target.
This is an essential session for every pathology practice, and will afford you the opportunity to interact directly with our experts and gain the benefit of their invaluable perspectives and recommendations. For one low price—just $245—you and your entire team at one location can take part in this insightful webinar. Best of all, you’ll be able to connect personally with our speakers when we open dialogue for questions from the audience.
The organizations represented in this webinar are strong regional pathology practices that have grown through both attention to patient care, and attention to the pathology marketplace. Register now and gain the benefit of their expert advice on the best practices for attaining premier status for your pathology practice!
Your Distinguished Presenters
Dr. Davis has been at the helm of PathGroup since 1996, the year the company was formed. He joined Associated Pathologists in 1986 and prior to that was an Assistant Professor in the Department of Pathology, Vanderbilt University Medical Center and School of Medicine following a Residency in Anatomic and Clinical Pathology at Vanderbilt.
Kathleen Fondren joined CellNetix from CHI Franciscan Health System, Highline Medical Center in September 2014 where she was the Assistant Administrator, Clinical Executive. As a member of the hospital senior executive team, Kathleen had oversight for multiple clinical departments, and made essential contributions to improving quality and reducing the overall cost of patient care.
Fondren was instrumental in the strategy, negotiation and closing of the most recent merger between CellNetix and PSIP. She has also been the key driver in improving financial performance and operational efficiency.
David Corwin is President of CellNetix, as well as Chief of Pathology and Director of Laboratories at the Swedish Medical Center in Seattle and PAML in Spokane. He is also a Clinical Associate Professor at the University of Washington School of Medicine.
Corwin is board certified in anatomic and clinical pathology as well as hematopathology, with subspecialty expertise in clinical chemistry (tumor markers, endocrine testing, serologic testing, and prenatal testing), flow cytometry, hematopathology, and laboratory administration.
Other notable experiences include serving as Chairman of the HCA Healthcare Network Institutional Review Board from 1989 to 2008 and as Group Leader of the Experimental Pathology Unit, Ludwig Institute for Cancer Research, Molecular Biology Branch, Bern Switzerland from 1981 to 1983.
cid=65409t11#rs” color=”#336699″ font_color=”#ffffff” target=”_blank”]